ALS

Measuring What Matters in ALS: The ALSFRS-R

May 20, 2026
Biotech Blogs

How the Klotho Gene Is Shaping Next-Gen Neurodegeneration Research
Life Science Podcast

Anti-Aging Gene Therapy in Alzheimer’s and ALS with Klotho Neurosciences’ Dr. Joseph Sinkule — Episode 243
Biotech Blogs

Top Clinical Trials to Watch in 2026: What’s Coming in Alzheimer’s, ALS and Gene Editing
Life Science Podcast

Restoring Lost Synapses in ALS, Fragile X and More with Spinogenix’s Dr. Peter Vanderklish — Episode 233
Life Science Podcast

Advancing Neurotherapeutics for Fragile X and Beyond with Spinogenix’s Dr. Craig Erickson — Episode 219
Life Science Podcast

Driving Neuro Innovation with Neurizon Therapeutics CEO Dr. Michael Thurn — Episode 218
Life Science Podcast

Restoring Synapses to Fight Neurodegeneration with Spinogenix CEO Dr. Stella Sarraf — Episode 217
Life Science Podcast

Innovating Treg Therapies for ALS and Alzheimer’s with Coya Therapeutics CEO Dr. Arun Swaminathan — Episode 200
Biotech Blogs

Working Faster Than the Speed of ALS to Transform Neurodegenerative Disease Research
Blogs

Amylyx’s Dedication to Neurodegenerative Disease Research: Insights Gained and Future Directions
Life Science Podcast

Golden Innovations: Nanocrystal Therapies for ALS and MS with Clene Nanomedicines’ Dr. Karen Ho
Life Science Podcast

FNIH’s Dr. Travaglia and ALS Patient Advocate Dr. Sethi Discuss New ALS Program
Life Science Podcast

The Road Ahead for Former ALS Hopeful Relyvrio ft. Amylyx’s Joshua Cohen and Justin Klee
Life Science Podcast

Treg Cell Therapy for Neurodegenerative Diseases – Interview with Dr. Howard Berman, CEO, Coya Therapeutics – Xtalks Life Science Podcast Ep. 155
Clinical Trial News

Amylyx to Discontinue ALS Drug Relyvrio After Failure in Confirmatory Trial